NCI Community Oncology Research Program Expands to More States

August 19, 2019

NCI Community Oncology Research Program Expands to More States
Alliance Boasts 27 NCORP Community Sites | 12 Minority/Underserved Community Sites | 1 Research Base
The National Cancer Institute (NCI) has awarded 53 grants to researchers in the  NCI Community Oncology Research Program (NCORP) to conduct multi-site cancer clinical trials and cancer care delivery studies in their communities.

New Trial: Alliance A071701 Genetic Testing/Brain Metastases

August 15, 2019

Alliance A071701: Genomically-guided treatment trial in brain metastases

Alliance investigator Priscilla Brastianos, MD, of Massachusetts General Hospital, leads this phase II trial that looks at how well genetic testing works in guiding treatment for patients with solid tumors that have spread to the brain. Several genes have been found to be altered or mutated in brain metastases such as NTRK

New Trial: Alliance A051701 High Grade B-Cell Lymphomas

August 6, 2019

Alliance A051701: Randomized phase II/III study of venetoclax (ABT199) plus dose-adjusted EPOCH-R for MYC/BCL2 double-hit and double protein expressing lymphomas

Overview: Alliance investigator Jeremy Abramson, MD, of Massachusetts General Hospital Cancer Center, leads this phase II/III trial that looks at whether it is possible to decrease the chance of high-grade B-cell lymphomas returning or getting worse b

Older News